e-Therapeutics: Newly in charge
AIM-listed drug discovery company e-Therapeutics plc has a new head. In early April, Raymond Barlow took over as Chief Executive Officer.
Most recently, Barlow was Executive Director of Corporate Development at Amgen Inc. based in Switzerland. The chemist by training, who earned his PhD in Chemistry from the University of Manchester, previously worked for Crucell NV, BD solutions ltd, AstraZeneca and others.
Johnson & Johnson
NovoArc
American Academy of Dermatology;doi.org/10.1016/j.jaad.2019.03.056